Dissociation between the effects of somatostatin (SS) and octapeptide SS-analogs on hormone release in a small subgroup of pituitary- and islet cell tumors

Journal of Clinical Endocrinology and Metabolism

Volumn 82, Issue 9, 1997, Pages 3011-3018

  Hofland, L J ^a,b   De Herder, W W ^a   Visser Wisselaar, H A ^a   Van Uffelen, C ^a   Waaijers, M ^a   Zuyderwijk, J ^a   Uitterlinden, P ^a   Kros, M J M ^a   Van Koetsveld, P M ^a   Lamberts, S W J ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPEPTIN; BROMOCRIPTINE; DOPAMINE RECEPTOR STIMULATING AGENT; OCTREOTIDE; QUINAGOLIDE; SOMATOSTATIN 14; SOMATOSTATIN 28; SOMATOSTATIN DERIVATIVE; VAPREOTIDE;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FOLLITROPIN RELEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOPHYSIS ADENOMA; INSULIN RELEASE; INSULINOMA; LUTEINIZING HORMONE RELEASE; PRIORITY JOURNAL; PROLACTIN RELEASE; PROLACTINOMA; RECEPTOR UPREGULATION;

EID: 9844220297     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.82.9.4252     Document Type: Article

References (24)

1. Bruns C, Weckbecker G, Raulf F, Kaupmann K, Schoeffter P, Hoyer D, Lübbert H. 1994 Molecular pharmacology of somatostatin-receptor subtypes. In: Wiedeman B, Kvols LK, Arnold R, Riecken EO, eds. Molecular and Cell Biological Aspects of Gastroenteropancreatic Neuroendocrine Tumor Disease. Ann N Y Acad Sci. 733:138-146.
2. Hoyer D, Lubbert H, Bruns. 1994 Molecular pharmacology of somatostatin receptors. Arch Pharmacol. 350:441-453.
3. Reisine T, Bell GI. 1995 Molecular Biology of somatostatin receptors. Endocr Rev. 16:427-442.
4. Hofland LJ, Visser-Wisselaar HA, Lamberts SWJ. 1995 Somatostatin analogs: clinical application in relation to human somatostatin receptor subtypes. Biochem Pharmacol. 50:287-297.
5. Lamberts SWJ, Krenning EP, Reubi JC. 1991 The role of somatostatin and its analogs in the diagnosis and treatment of tumors. Endocr Rev. 12:450-482.
6. Reubi JC, Laissue J, Krenning E, Lamberts SWJ. 1992 Somatostatin receptors in human cancer: incidence, characteristics, functional correlates and clinical implications. J Steroid Biochem Mol Biol. 43:27-35.
7. Greenman Y, Melmed S. 1994 Heterogeneous expression of two somatostatin receptor subtypes in pituitary tumors. J Clin Endocrinol Metab. 78:398-403.
8. Kubota A, Yamada Y, Kagimoto S, Shimatsu A, Imamura M, Tsuda K, Imura H, Seino S, Seino Y. 1994 Identification of somatostatin receptor subtypes and an implication for the efficacy of somatostatin analogue SMS 201-995 in treatment of human endocrine tumors. J Clin Invest. 93:1321-1325.
9. Raynor K, Murphy W, Coy D, Taylor J, Moreau J-P, Yasuda K, Bell GI, Reisine T. 1993 Cloned SRIF receptors: identification of subtype selective peptides and demonstration of high affinity binding of linear peptides. Mol Pharmacol. 43:838-844.
10. Hofland LJ, van Koetsveld PM, Waaijers M, Zuyderwijk J, Lamberts SWJ. 1994 Relative potencies of the somatostatin analogs octreotide, BIM-23014, and RC-160 on the inhibition of hormone release by cultured human endocrine tumor cells and normal rat anterior pituitary cells. Endocrinology. 134:301-306.
11. de Bruin TWA, Kwekkeboom DJ, van't Verlaat JW, Reubi J-C, Krenning EP, Lamberts SWJ, Croughs RJM. 1992 Clinically nonfunctioning pituitary adenoma and octreotide response to long term high dose treatment, and studies in vitro. J Clin Endocrinol Metab. 75:1310-1317.
12. Klibansky A, Alexander JH, Bikkal HA, Hsu DW, Swearingen B, Zervas NT. 1991 Somatostatin regulation of glycoprotein hormone and free subunit secretion in clinically nonfunctioning and somatotroph adenomas in vitro. J Clin Endocrinol Metab. 73:1248-1255.
13. Hofland LJ, van Koetsveld PM, Verleun TM, Lamberts SWJ. 1989 Glycoprotein hormone α-subunit and prolactin release by cultured pituitary adenoma cells from acromegalic patients: correlation with GH release. Clin Endocrinol. 30:601-611.
14. Lamberts SWJ, Hofland LJ, van Koetsveld PM, Reubi J-C, Bruining HA, Bakker WH, Krenning EP. 1990 Parallel in vivo and in vitro detection of functional somatostatin receptors in human endocrine pancreatic tumors: consequences with regard to diagnosis, localization, and therapy. J Clin Endocrinol Metab. 71:566-574.
15. Kwekkeboom DJ, Hofland LJ, van Koetsveld PM, Singh R, van den Berge JH, Lamberts SWJ. 1990 Bromocriptine increasingly suppresses the in vitro gonadotropin and α-subunit release from pituitary adenomas during long-term culture. J Clin Endocrinol Metab. 71:718-724.
16. Reubi JC, Kvols LK, Waser B, Nagorney DM, Heitz PU, Charboneau JW, Reading CC, Moertel C. 1990 Detection of somatostatin receptors in surgical and percutaneous needle biopsy samples of carcinoids and islet cell carcinomas. Cancer Res. 50:5969-5977.
17. Reubi JC, Schaer JC, Waser B, Mengod G. 1994 Expression and localization of somatostatin receptor SSTR1, SSTR2, and SSTR3 messenger RNAs in primary human tumors using in situ hybridization. Cancer Res. 54:3455-3459.
18. Reubi J-C, Waser B, Lamberts SWJ, Mengod G. 1993 Somatostatin (SRIH) messenger ribonucleic acid expression in human neuroendocrine and brain tumors using in situ hybridization histochemistry: comparison with SRIH receptor content. J Clin Endocrinol Metab. 76:642-647.
19. Greenman Y, Melmed S. 1994 Expression of three somatostatin receptor subtypes in pituitary adenomas: evidence for preferential SSTR5 expression in the mammosomatotroph lineage. J Clin Endocrinol Metab. 79:724-729.
20. Panetta R, Patel YC. 1995 Expression of mRNA for all five human somatostatin receptors (hSSTR1-5) in pituitary tumors. Life Sci. 56:333-342.
21. Miller GM, Alexander JM, Bikkal HA, Katznelson L, Zervas NT, Klibansky A. 1995 Somatostatin receptor subtype gene expression in pituitary adenomas. J Clin Endocrinol Metab. 80:1386-1392.
22. Lamberts SWJ. 1988 The role of somatostatin in the regulation of anterior pituitary hormone secretion and the use of its analogs in the treament of human pituitary tumors. Endocr Rev. 9:417-436.
23. Lamberts SWJ, Zweens M, Klijn JGM, van Vroonhoven CCJ, Stefanko SZ, del Pozo E. 1986 The sensitivity of growth hormone and prolactin secretion to the somatostatin analogue SMS 201-995 in patients with prolactinomas and acromegaly. Clin Endocrinol. 25:201-212.
24. Murabe H, Shimatsu A, Ihara C, Mizuta H, Nakamura Y, Nagata I, Kikuchi H, Nakao K. 1996 Expression of somatostatin receptor (sstr) subtypes in pituitary adenomas: quantitative analysis of sstr2 mRNA by reverse transcriptase-polymerase chain reaction. J Neuroendocrinol. 8:605-610.